Proteomics

Dataset Information

0

A glucagon variant, glucagon 1-61, identified in man, controls blood glucose through regulation of insulin secretion and hepatic glucose production


ABSTRACT: Glucagon is secreted from pancreatic α-cells, and hypersecretion (hyperglucagonemia) contributes to diabetic hyperglycemia. Molecular heterogeneity in hyperglucagonemia is poorly investigated. By screening human plasma by high-resolution-proteomics, we identified several glucagon variants among which proglucagon 1-61 (PG 1-61) appears to be the most abundant form. PG 1-61 was secreted in obese subjects before and as well after gastric bypass surgery with protein and fat as the main drivers for secretion before surgery, but glucose after. Studies in hepatocytes and in β-cells demonstrated that PG 1-61 dose-dependently increased levels of cAMP, through the glucagon receptor, and increased insulin secretion and protein levels of enzymes regulating glycogenolysis and gluconeogenesis. As a consequence, PG 1-61 increased blood glucose and plasma insulin and decreased plasma levels of amino acids in vivo. Glucagon variants, such as PG 1-61, may contribute to glucose regulation by stimulating hepatic glucose production and insulin secretion.

INSTRUMENT(S): LTQ Orbitrap

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Plasma

DISEASE(S): Type 2 Diabetes Mellitus

SUBMITTER: Mario Oroshi  

LAB HEAD: Felix Meissner

PROVIDER: PXD005677 | Pride | 2017-10-20

REPOSITORIES: Pride

Similar Datasets

2014-04-01 | E-GEOD-48815 | biostudies-arrayexpress
2014-04-01 | GSE48815 | GEO
2022-06-09 | PXD028715 | Pride
2020-06-05 | PXD016690 | Pride
2024-03-31 | GSE171352 | GEO
2021-04-07 | GSE130329 | GEO
2020-07-28 | GSE151588 | GEO
2022-10-11 | E-MTAB-12060 | biostudies-arrayexpress
2022-12-09 | GSE211105 | GEO
2016-11-07 | GSE87586 | GEO